knowledge -WSS

knowledge

author：Wikipedia 2025-10-01 06:00:58 - browse：98448

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Cigna, Humana reportedly in talks to merge

WSS

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Heart disease and mental health: A look at cardiac psychology

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Takeda, Janssen join wearable maker to measure scratching

entertainment

knowledge

focus

Apple is now the first public company to be valued at $3 trillion

Flagship Pioneering launches a new biotech in two countries

Affirmative action in medical school literally saved lives

JPM 2024: Verve Therapeutics looks to mainstream genome editing

Psychedelics group wrestles with new pharma identity

Takeda, Janssen join wearable maker to measure scratching

Jerome Adams on the need for new antivirals for Covid

FDA investigates CAR

In age of alternative facts, a scholarly course on calling out crap

30 years of 'Listening to Prozac'

hotspot

How I ended up pumping milk in a bathroom stall at JPM 2024

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Flagship Pioneering launches a new biotech in two countries

UnitedHealth’s Optum accused of antitrust violations in California

The SUPPORT Act is critical to fighting the opioid crisis

leisure time

knowledge

leisure time

hotspot